Highland Capital Management (Texas)’s GSK GSK Stock Holding History

Highland Capital Management (Texas)’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,000	Closed	-$209K	–	339
2019 Q1	$209K	Buy	+4,000	New	+$200K	0.01%	297
2015 Q3	–	Sell	-64,830	Closed	-$1.18M	–	290
2015 Q2	$1.18M	Hold	64,830	–	–	0.02%	210
2015 Q1	$1.28M	Buy	64,830 +850	+1%	+$48.7K	0.03%	201
2014 Q4	$1.98M	Buy	+63,980	New	+$3.58M	0.07%	137
2014 Q2	–	Sell	-33,809	Closed	-$2.26M	–	283
2014 Q1	$2.26M	Buy	+33,809	New	+$2.29M	0.09%	124

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Highland Capital Management (Texas)'s GSK Position: Q2 2019 in Review

Highland Capital Management (Texas) sold out of GSK (GSK) in Q2 2019, closing a stake of 4,000 shares — an estimated $209K sold.

Highland Capital Management (Texas) first reported a position in GSK in Q1 2014 and held it in 5 quarters. The position peaked at $2.26M in Q1 2014. 804 funds tracked by Wall St. Rank hold GSK as of Q2 2019.

Highland Capital Management (Texas) reported no remaining GSK position as of Q2 2019 after selling out during the quarter.
Highland Capital Management (Texas) sold 4,000 GSK shares in Q2 2019, an estimated $209K.
Highland Capital Management (Texas) first reported a position in GSK in Q1 2014 and held it in 5 quarters.
Highland Capital Management (Texas)'s GSK position peaked at $2.26M in Q1 2014.
804 funds tracked by Wall St. Rank held GSK as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.